Q2 2023 · 13F-HR
Redmile Group, LLCholdings as filed
Filed 2023-08-14 · accession 0001104659-23-091352
$2.61B
Reported value
72
Positions
2023-06-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 45253H101 | IMGNEUR | IMMUNOGEN INC | $334.6M | 12.8% | 17,730,417 | Common | SOLE |
| 501147102 | KRYS | KRYSTAL BIOTECH INC | $301.3M | 11.6% | 2,566,661 | Common | SOLE |
| 03152W109 | AM6 | AMICUS THERAPEUTICS INC | $245.8M | 9.43% | 19,566,961 | Common | SOLE |
| 76029N106 | REPL | REPLIMUNE GROUP INC | $102.6M | 3.94% | 4,420,533 | Common | SOLE |
| 00973Y108 | AKRO | AKERO THERAPEUTICS INC | $84.6M | 3.25% | 1,811,672 | Common | SOLE |
| 05105P107 | AUGX | AUGMEDIX INC | $75.2M | 2.89% | 15,630,327 | Common | SOLE |
| 24344T101 | DCPHEUR | DECIPHERA PHARMACEUTICALS IN | $68.7M | 2.64% | 4,878,566 | Common | SOLE |
| 31189P102 | FATE | FATE THERAPEUTICS INC | $62.5M | 2.40% | 13,124,427 | Common | SOLE |
| 15117B202 | CLDX | CELLDEX THERAPEUTICS INC NEW | $57.5M | 2.21% | 1,696,004 | Common | SOLE |
| G5509L101 | LIVN | LIVANOVA PLC | $56.6M | 2.17% | 1,100,492 | Common | SOLE |
| 148806102 | CTLTEUR | CATALENT INC | $50.4M | 1.93% | 1,162,166 | Common | SOLE |
| 98985Y108 | ZYME | ZYMEWORKS INC | $48.9M | 1.88% | 5,661,230 | Common | SOLE |
| 729139105 | PLRX | PLIANT THERAPEUTICS INC | $48.5M | 1.86% | 2,678,099 | Common | SOLE |
| 70975L107 | PEN | PENUMBRA INC | $47.8M | 1.84% | 138,970 | Common | SOLE |
| 07373V105 | BEAM | BEAM THERAPEUTICS INC | $47.4M | 1.82% | 1,485,199 | Common | SOLE |
| 98420N105 | XENE | XENON PHARMACEUTICALS INC | $43.1M | 1.66% | 1,120,476 | Common | SOLE |
| 501575104 | KYMR | KYMERA THERAPEUTICS INC | $43.0M | 1.65% | 1,868,507 | Common | SOLE |
| 09061G101 | BMRN | BIOMARIN PHARMACEUTICAL INC | $42.4M | 1.63% | 489,208 | Common | SOLE |
| G50871105 | JAZZ | JAZZ PHARMACEUTICALS PLC | $42.4M | 1.63% | 341,882 | Common | SOLE |
| 86150R107 | STOK | STOKE THERAPEUTICS INC | $42.0M | 1.61% | 3,955,188 | Common | SOLE |
| 75901B107 | RGNX | REGENXBIO INC | $40.5M | 1.55% | 2,026,576 | Common | SOLE |
| 252131107 | DXCM | DEXCOM INC | $37.2M | 1.43% | 289,161 | Common | SOLE |
| 45258J102 | IMVT | IMMUNOVANT INC | $36.4M | 1.40% | 1,921,152 | Common | SOLE |
| 036752103 | ELV | ELEVANCE HEALTH INC | $34.8M | 1.34% | 78,313 | Common | SOLE |
| 80706P103 | SRRK | SCHOLAR ROCK HLDG CORP | $33.2M | 1.27% | 4,403,840 | Common | SOLE |
| 92332V107 | VTYXUSD | VENTYX BIOSCIENCES INC | $30.8M | 1.18% | 940,493 | Common | SOLE |
| H0036K147 | ADCT | ADC THERAPEUTICS SA | $30.2M | 1.16% | 14,049,935 | Common | SOLE |
| 67080M103 | NRIX | NURIX THERAPEUTICS INC | $28.5M | 1.10% | 2,857,309 | Common | SOLE |
| 449585108 | 1K0 | IGM BIOSCIENCES INC | $27.4M | 1.05% | 2,971,542 | Common | SOLE |
| 863667101 | SYK | STRYKER CORPORATION | $26.2M | 1.01% | 85,899 | Common | SOLE |
| 760273102 | RPTX | REPARE THERAPEUTICS INC | $25.7M | 0.99% | 2,428,335 | Common | SOLE |
| 19240Q201 | COGT | COGENT BIOSCIENCES INC | $24.3M | 0.93% | 2,053,333 | Common | SOLE |
| 159864107 | CRL | CHARLES RIV LABS INTL INC | $24.0M | 0.92% | 114,351 | Common | SOLE |
| 98956P102 | ZBH | ZIMMER BIOMET HOLDINGS INC | $22.0M | 0.85% | 151,372 | Common | SOLE |
| 46266C105 | IQV | IQVIA HLDGS INC | $21.2M | 0.81% | 94,409 | Common | SOLE |
| 101137107 | BSX | BOSTON SCIENTIFIC CORP | $21.2M | 0.81% | 391,178 | Common | SOLE |
| 444859102 | HUM | HUMANA INC | $20.7M | 0.79% | 46,310 | Common | SOLE |
| 92539P101 | — | VERVE THERAPEUTICS INC | $19.9M | 0.76% | 1,061,960 | Common | SOLE |
| 29384C108 | TRDA | ENTRADA THERAPEUTICS INC | $19.9M | 0.76% | 1,311,572 | Common | SOLE |
| 74168J101 | PRME | PRIME MEDICINE INC | $19.4M | 0.74% | 1,324,350 | Common | SOLE |
| 12674W109 | CABA | CABALETTA BIO INC | $17.7M | 0.68% | 1,370,299 | Common | SOLE |
| 82024L103 | STTK | SHATTUCK LABS INC | $17.5M | 0.67% | 5,619,914 | Common | SOLE |
| 282559103 | ETNBGBP | 89BIO INC | $14.4M | 0.55% | 761,955 | Common | SOLE |
| 39868T105 | 2JQ | GRITSTONE BIO INC | $13.4M | 0.51% | 6,860,226 | Common | SOLE |
| 03589W102 | ANNX | ANNEXON INC | $12.3M | 0.47% | 3,503,190 | Common | SOLE |
| 00091E109 | ABSI | ABSCI CORPORATION | $12.2M | 0.47% | 8,031,094 | Common | SOLE |
| 01671P100 | ALLKGUSD | ALLAKOS INC | $10.0M | 0.38% | 2,283,594 | Common | SOLE |
| 85916J409 | STXS | STEREOTAXIS INC | $9.8M | 0.37% | 6,373,898 | Common | SOLE |
| 046513107 | ATRAGBX | ATARA BIOTHERAPEUTICS INC | $9.7M | 0.37% | 6,048,123 | Common | SOLE |
| 00166B105 | ALXO | ALX ONCOLOGY HLDGS INC | $9.6M | 0.37% | 1,283,289 | Common | SOLE |
| 58406B103 | — | MEDAVAIL HOLDINGS INC | $8.5M | 0.33% | 34,604,516 | Common | SOLE |
| 75382E109 | — | RAPT THERAPEUTICS INC | $8.1M | 0.31% | 431,919 | Common | SOLE |
| 00445A100 | — | ACELYRIN INC | $7.6M | 0.29% | 364,493 | Common | SOLE |
| T9224W109 | STVN | STEVANATO GROUP S P A | $7.1M | 0.27% | 218,169 | Common | SOLE |
| 019818103 | — | ALLOVIR INC | $6.5M | 0.25% | 1,907,969 | Common | SOLE |
| 30050B101 | EVH | EVOLENT HEALTH INC | $6.5M | 0.25% | 213,432 | Common | SOLE |
| 59045L106 | — | MERSANA THERAPEUTICS INC | $5.6M | 0.21% | 1,698,626 | Common | SOLE |
| 398438408 | GRFS | GRIFOLS S A | $5.5M | 0.21% | 600,684 | Common | SOLE |
| 67080N101 | NUVB | NUVATION BIO INC | $5.5M | 0.21% | 3,031,009 | Common | SOLE |
| 83444K105 | SLGCUSD | SOMALOGIC INC | $4.3M | 0.17% | 1,870,839 | Common | SOLE |
| N51517105 | 4PKB | LAVA THERAPEUTICS NV | $4.2M | 0.16% | 2,074,372 | Common | SOLE |
| 808644108 | — | SCIENCE 37 HOLDINGS INC | $4.2M | 0.16% | 19,808,234 | Common | SOLE |
| 43906K100 | HOOKGBP | HOOKIPA PHARMA INC | $2.9M | 0.11% | 3,288,469 | Common | SOLE |
| 98422E103 | XERS | XERIS BIOPHARMA HOLDINGS INC | $2.7M | 0.11% | 1,046,587 | Common | SOLE |
| 46185L103 | NVTA1EUR | INVITAE CORP | $2.6M | 0.10% | 2,280,403 | Common | SOLE |
| 64049K104 | — | NEOLEUKIN THERAPEUTICS INC | $2.4M | 0.09% | 2,912,228 | Common | SOLE |
| 00449L102 | 698 | ACHILLES THERAPEUTICS PLC | $1.5M | 0.06% | 1,608,089 | Common | SOLE |
| 00534A102 | IVVD | INVIVYD INC | $1.5M | 0.06% | 1,440,725 | Common | SOLE |
| 02080L102 | TKNO | ALPHA TEKNOVA INC | $824,635 | 0.03% | 308,852 | Common | SOLE |
| 835431107 | — | SONENDO INC | $677,458 | 0.03% | 498,131 | Common | SOLE |
| 00653A107 | ADAPY | ADAPTIMMUNE THERAPEUTICS PLC | $661,936 | 0.03% | 715,607 | Common | SOLE |
| 04965G109 | BCELUSD | ATRECA INC | $433,800 | 0.02% | 442,653 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.